Aureus Asset Management, LLC Pfizer Inc Transaction History

Aureus Asset Management, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $52,608 - $60,411	-2,032 Reduced 20.41%	7,925 $219,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $43,036 - $55,899	-1,647 Reduced 14.19%	9,957 $286,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $32,410 - $37,885	1,010 Added 9.53%	11,604 $384,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $23,839 - $27,581	-660 Reduced 5.86%	10,594 $388,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $90,636 - $117,995	-2,301 Reduced 16.98%	11,254 $459,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $565,921 - $738,747	13,555 New	13,555 $694,000
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $171,196 - $212,133	-3,742 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $154,619 - $229,197	3,742 New	3,742 $221,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $368,165 - $472,939	-9,380 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $336,835 - $381,578	9,380 New	9,380 $367,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $306,937 - $337,222	-8,185 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $423 - $482	11 Added 0.13%	8,185 $357,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $206 - $250	6 Added 0.07%	8,174 $360,000
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $74,633 - $79,567	2,263 Added 38.32%	8,168 $296,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $37,685 - $43,720	-1,181 Reduced 16.67%	5,905 $210,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $19,789 - $20,997	-595 Reduced 7.75%	7,086 $257,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $238,111 - $262,306	7,681	7,681 $274,000

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aureus Asset Management, LLC with notifications on news.